2008

Arendt G, Nolting T. Neurologische Komplikationen der HIV-Infektion. Nervenarzt 2008; 79: 1449-1463.

Arendt G, Nolting T. Schmerztherapie bei HIV-Patienten. MMW Fortschritte der Medizin2008; 150: 16-8.

Biermann-Ruben K, Jonas M, Kessler K, Siebner HR, Bäumer T, Schnitzler A, Münchau A. Observing repetitive finger movements modulates response times of auditorily cued finger movements. Brain and Cognition 2008; 68: 107-113.

Biermann-Ruben K, Kessler K, Jonas M, Siebner HR, Bäumer T, Münchau A, Schnitzler A. Rigth hemisphere contributions to imitation tasks. European Journal of Neuroscience 2008; 27: 1843-1855.

Bode FJ, Stephan M, Suhling H, Pabst R, Straub RH, Raber KA, Bonin M, Nguyen HP, Riess O, Bauer A, Sjoberg C, Petersén A, von Hörsten S. Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. Human Molecular Genetics 2008; 17: 2595-2609.

Boy C, Meyer PT, Kircheis G, Holschbach MH, Herzog H, Elmenhorst D, Kaiser HJ, Coenen HH, Häussinger D, Zilles K, Bauer A. Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis. European Journal of Nuclear Medicine and Molecular Imaging 2008; 35: 589-597.

Brin MF, Comella CL, Jankovic J, Lai F, Math M, Naumann M; for the CD-017 BoNTA Study Group [Hefter H]. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. Movement Disorders 2008; 23: 1353-1360.

Brosig T, Hoinkes A, Seitz RJ, Sandmann W, Huber R, Siebler M. Ultrasound turbulence index during thromboendarterectomy predicts postoperative cerebral microembolism. Cerebrovascular Diseases 2008; 26: 87-92.

Bütefisch CM, Weßling M, Netz J, Seitz RJ, Hömberg V. Relationship between interhemispheric inhibition and motor cortex excitability in subacute stroke patients. Neurorehabilitation and Neural Repair 2008; 22: 4-21.

Cepok S, Hemmer B, Büssow K. Identification of target antigens in CNS inflammation by protein array technique. In: Krishnarao Appasani, PhD., MBA (ed.) BioArrays: From Basics to Diagnostics. Humana Press, Totowa, NJ, USA, 2008; 137-148.

Cramer SC, Seitz RJ. Imaging functional recovery from stroke. In: Aminoff MJ, Boller F, Swaab DF, Fisher M (eds.) Handbook of Clinical Neurology: Stroke Part III: Investigation and Management. 3rd series, Vol. 94, Elsevier, Amsterdam, 2008; 1097-1117.

de Lussanet MH, Fadiga L, Michels L, Seitz RJ, Kleiser R, Lappe M. Interaction of visual hemifield and body view in biological motion perception. European Journal of Neuroscience 2008; 27: 514-522.

del Pilar Martin M, Cravens PD, Winger R, Kieseier BC, Cepok S, Eagar TN, Zamvil SS, Weber MS, Frohman EM, Kleinschmidt-DeMasters BK, Montine TJ, Hemmer B, Marra CM, Stüve O. Rituximab depletes B lymphocytes in cerebral perivascular spaces. Archives of Neurology 2008; 65: 1596-1603.

Dehmel T, Goebel HH, Hartung HP, Lehmann H, Wiendl H, Kieseier BC. The metalloproteinase-disintegrin ADAM10 is exclusively expressed by type I muscle fibres. Muscle & Nerve 2008; 38: 1049-1051.

Dehnhardt M, Zoriy MV, Khan Z, Reifenberger G, Ekström TJ, Becker JS, Zilles K, Bauer A. Element distribution is altered in a zone surrounding human glioblastoma multiforme. Journal of Trace Elements in Medicine and Biology 2008; 22: 17-23.

Dihné M, Schuier FJ, Schuier M, Cordes J, Hartung HP, Knehans A, Müller S. Hashimoto encephalopathy following lodine 131 (131l) radiotherapy of Graves disease. Archives of Neurology 2008; 65: 282-283.

Dittmer S, Sahin M, Pantlen A, Saxena A, Toutzaris D, Pina AL, Geerts A, Golz S, Methner A. The constitutively active orphan G-protein coupled receptor GPR39 protects from cell death by increasing secretion of pigment epithelial-derived growth factor. Journal of Biological Chemistry 2008; 283: 7074-7081.

Eickhoff SB, Dafotakis M, Grefkes C, Stöcker T, Shah NJ, Schnitzler A, Zilles K, Siebler M. fMRI reveals cognitive and emotional processing in a long-term comatose patient. Experimental Neurology 2008; 214: 240-246.

Farrell R, Bendtzen K, Bertolotto A, Clark B, Comabella M, Deisenhammer F, Fogdell-Hahn A, Giovannoni G, Hartung HP, Hemmer B, Hillert J, Kappos L, Killestein J, Lindberg R, Montalban X, Polman C, Sorensen PS, Goodin DS, Hurwitz B, Noronha A. Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis. Journal of International Medical Research 2008; 36: 204-210.

Fazekas F, Lublin FD, Li D, Freedman MS, Hartung HP, Rieckmann P, Sørensen S, Maas-Enriquez M, Sommerauer B, Hanna K; for the PRIVIG Study Group and the UBC MS/MRI Research Group. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: A dose-finding trial. Neurology 2008; 71: 265-271.

Flögel U, Ding Z, Hardung H, Jander S, Reichmann G, Jacoby C, Schubert R, Schrader J. In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation 2008; 118: 140-148.

Girgenrath M, Bock O, Seitz RJ. An fMRI study of brain activation in a visual adaptation task: activation limited to sensory guidance. Experimental Brain Research 2008; 184: 561-569.

Gold R, Kieseier BC, Chan A, Rieckmann P, Hartung HP. Diagnostik und Therapie der Multiplen Sklerose. In: Diener, Putzki (eds.) Leitlinien für Diagnostik und Therapie in der Neurologie. Georg Thieme Verlag, Stuttgart, 2008; pp 364-383.

Greschat S, Schira J, Küry P, Rosenbaum C, de Souza S, Kögler G, Wernet P, Müller HW. Unrestricted somatic stem cells from human umbilical cord blood can be differentiated into neurons with a dopaminergic phenotype. Stem Cells and Development 2008; 17: 221-232.

Gripp S, Peiper M, Matuschek C, Giro C, Steinbach G, Hermsen D, van Griensven M, Budach W, Engers R, Gerber PA, Hefter H, Spiess B, Orth K, Bölke E. Validitiy of s-100 B in patients after brain radiation. European Journal of Medical Research 2008; 13: 299-303.

Hariz MI, Rehncrona S, Quinn NP, Speelman JD, Wensing C, et. al. [Schnitzler A]; Multicentre Advanced Parkinson's Disease Deep Brain Stimulation Group. Multicenter study on deep brain stimulation in Parkinson's disease: an independent assessment of reported adverse events at 4 years. Movement Disorders 2008; 23: 416-421.

Hartmann S, Missimer JH, Stoeckel C, Abela E, Shah J, Seitz RJ, Weder BJ. Functional connectivity in tactile object discrimination: a principal component analysis of an event related fMRI-Study. PLoS ONE 2008; 3: e3831.

Hartung HP. Advances in the understanding of the mechanism of action of IVIg. Journal of Neurology 2008; 255, Suppl. 3: 3-6.

Hartung HP, Kieseier BC. Advances in biotechnology and novel insights into pathophysiology have contributed to an increased understanding of the pathomechanisms of diseases affecting the peripheral nervous system. Editorial. Current Opinion in Neurology 2008; 21: 517-518.

Hartung HP, Kieseier BC, Schroeter M. Neuromuskuläre Störungen beim Intensivpatienten, Critical-illness-Neuropathie und andere neurologische Störungen. In: Burchardi H, Larsen R, Kuhlen R, Jauch KW, Schölmerich J (eds.) Die Intensivmedizin 10. Auflage, Springer Medizin Verlag, Heidelberg, 2008; 695-706.

Hartung HP. Book review on Hauser SL, Josephson SA, English JD, Engstrom JW. Harrison's neurology in clinical medicine. Archives of Neurology 2008; 65: 554.

Hefter H. Aspekte der möglichen Komplexität zervikaler Dystonien. Nervenarzt 2008; 79 Suppl. 1: 15-18.

Heinen A, Kremer D, Göttle P, Kruse F, Hasse B, Lehmann H, Hartung HP, Küry P. The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelination. Proceedings of the National Academy of Sciences of the United States of America 2008; 105: 8748-8753.

Heinen A, Kremer D, Hartung HP, Küry P. p57 (kip2)'s role beyond schwann cell cycle control. Cell Cycle 2008; 7: 2781-2786.

Herzog H, Elmenhorst D, Winz O, Bauer A. Biodistribution and radiation dosimetry of the A1adenosine receptor ligand 18F-CPFPX determined from human whole-body PET. European Journal of Nuclear Medicine and Molecular Imaging 2008; 35: 1499-1506.

Hoffmann S, Cepok S, Grummel V, Lehmann-Horn K, Hackermueller J, Stadler PF, Hartung HP, Berthele A, Deisenhammer F, Wasmuth R, Hemmer B. HLA-DRB1*0401 and HLA-DRB1*0408 are strongly associated with the development of antibodies against interferon-beta therapy in multiple sclerosis. American Journal of Human Genetics 2008; 83: 219-227.

Hofstetter HH, Stüve O, Hartung HP. Temporary leukocyte effects in temporal lobe epilepsy? Experimental Neurology 2008; 212: 239-241.

Hofstetter HH, Stüve O, Hartung HP. Fine-tuning the homeostasis of regulatory T cells: new mechanism of immunomodulatory therapy in multiple sclerosis. Archives of Neurology2008; 65: 1417-1418.

Hu W, Kieseier B, Frohman E, Eagar TN, Rosenberg RN, Hartung HP, Stüve O. Prion proteins: physiological functions and role in neurological disorders. Journal of the Neurological Sciences 2008; 264: 1-8.

Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, Hartung HP, Latov N, Merkies I, van Doorn P; on behalf of the ICE Study Group. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurology 2008; 7: 136-144.

Hurlemann R, Matusch A, Kuhn KU, Berning J, Elmenhorst D, Winz O, Kolsch H, Zilles K, Wagner M, Maier W, Bauer A. 5-HT2A receptor density is decreased in the at-risk mental state. Psychopharmacology 2008; 195: 579-590.

Jörgens S, Biermann-Ruben K, Kurz MW, Flügel C, Daehli Kurz K, Antke C, Hartung HP, Seitz RJ, Schnitzler A. Word deafness as a cortical auditory processing deficit: a case report with MEG. Neurocase 2008; 14: 307-316.

Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Yang M, Eraksoy M, Meluzinova E, Rektor I, Dawson KT, Sandrock AW, O'Neill GN; BG-12 Phase IIb Study Investigators [Hartung HP]. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet 2008; 372: 1463-1472.

Kieseier BC, Wiendl H, Leussink VI, Stüve O. Immunomodulatory treatment strategies in multiple sclerosis. Journal of Neurology 2008; 255: 15-21.

Kieseier BC, Lehmann HC, Hartung HP. Immunneuropathien - von der Pathogenese zur Therapie. Aktuelle Neurologie 2008; 35: 177-184.

Kieseier BC, Meyer zu Hörste G, Lehmann HC, Gold R, Hartung HP. Intravenous immunoglobulins in the treatment of immune neuropathies. Current Opinion in Neurology2008; 21: 555-562.

Killestein J, Hartung HP. Interferon-beta in multiple sclerosis: predicting response at an early stage. Journal of Neurology, Neurosurgery and Psychiatry 2008; 79: 616-617.

König FB, Wildemann B, Nessler S, Zhou D, Hemmer B, Metz I, Hartung HP, Kieseier BC, Brück W. Persistence of immunopathological and radiological traits in multiple sclerosis. Archives of Neurology 2008; 65: 1527-1532.

Kraemer C, Evers S, Nolting T, Arendt G, Husstedt IW. Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy. Journal of Neurology 2008; 255: 526-531.

Kreuter A, Potthoff A, Brockmeyer NH, Gambichler T, Stücker M, Altmeyer P, Swoboda J, Pfister H, Wieland U; for the German Competence Network HIV/AIDS [Arendt G]. Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men. Journal of Investigative Dermatology 2008; 128: 2078-2983.

Kruse F, Brazda N, Küry P, Bosse F, Müller HW. Analysing complex gene expression profiles in sensorimotor cortex following spinal cord injury and regeneration promoting treatment. In: Müller HW (ed.) Neural Degeneration and Repair - Gene Expression Profiling, Proteomics, and Systems Biology Wiley-VCH Verlag, Weinheim, 2008; 61-89.

Kurz MW, Rudolph T, Arendt G, Farbu E. A 64-year old woman with otitis media, splenic infarction and pareses. Tidsskrift for den Norske Lægeforening 2008; 128: 1185-1187.

Lee JI, Wittsack HJ, Christaras A, Miese FR, Siebler M. Normalization of brain tissue lactate after hyperbaric oxygen therapy in a progressive stroke patient. Cerebrovascular Diseases2008; 26: 447-448.

Lehmann HC, Hoffmann FR, Fusshoeller A, Meyer zu Hörste GM, Hetzel R, Hartung HP, Schroeter M, Kieseier BC. The clinical value of therapeutic plasma exchange in multifocal motor neuropathy. Journal of the Neurological Sciences 2008; 271: 34-39.

Lehmann HC, Hartung HP. Complementing the therapeutic armamentarium for Miller Fisher Syndrome and related immune neuropathies. Brain 2008; 131: 1168-1170.

Lehmann HC, Hartung HP, Meyer zu Hörste G, Kieseier BC. Plasma exchange in immune-mediated neuropathies. Current Opinion in Neurology 2008; 21: 547-554.

Leinweber B, Möller JC, Scherag A, Reuner U, Güther P, Lang CJ, Schmidt HH, Schrader C, Bandmann O, Czlonkowska A, Oertel WH, Hefter H. Evaluation of the unified Wilson's disease rating scale (UWDRS) in German patients with treated Wilson's disease. Movement Disorders 2008; 23: 54-62.

Leussink VI, Lehmann HC, Hartung HP, Gold R, Kieseier BC. Type III systemic allergic reaction to natalizumab. Archives of Neurology 2008; 65: 851-852.

Leussink VI, Lehmann HC, Meyer zu Hörste G, Hartung HP, Stüve O, Kieseier BC. Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab: evidence for disease heterogeneity. Journal of Neurology 2008; 255: 1436-1438.

Linker RA, Kieseier BC. Innovative therapy with monoclonal antibodies in multiple sclerosis. Therapeutic Advances in Neurological Disorders 2008; 1: 33-42.

Linker RA, Kieseier BC. Therapieentscheidungen bei Multipler Sklerose. Nervenarzt 2008; 79: 1123-1134.

Linker RA, Kieseier BC, Gold R. Identification and development of new therapeutics for mutliple sclerosis. Trends in Pharmacological Sciences 2008; 29: 558-565.

Martinez-Torres F, Menon S, Pritsch M, Victor N, Jenetzky E, Jensen K, Schielke E, Schmutzhard E, de Gans J, Chung CH, Luntz S, Hacke W, Meyding-Lamadé U; GACHE Investigators [Hartung HP]. Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial (ISRCTN45122933). BMC Neurology 2008; 8: 40.

Menge T, Weber MS, Hemmer B, Kieseier BC, von Büdingen HC, Warnke C, Zamvil SS, Boster A, Khan O, Hartung HP, Stüve O. Disease-modifying agents for mutliple sclerosis: recent advances and future prospects. Drugs 2008; 68: 2445-2468.

Meuth SG, Kanyshkova T, Melzer N, Bittner S, Kieseier BC, Budde T, Wiendl H. Altered neuronal expression of TASK1 and TASK3 potassium channels in rodent and human autoimmune CNS inflammation. Neuroscience Letters 2008; 446: 133-138.

Meyer zu Hörste G, Hu W, Hartung HP, Lehmann HC, Kieseier BC. The immunocompetence of Schwann cells. Muscle & Nerve 2008; 37: 3-13.

Moro E, Volkmann J, König IR, Winkler S, Hiller A, Hassin-Baer S, Herzog J, Schnitzler A, Lohmann K, Pinsker MO, Voges J, Djarmatic A, Seibler P, Lozano AM, Rogaeva E, Lang AE, Deuschl G, Klein C. Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism. Neurology 2008; 70: 1186-1191.

Müller HW (ed.) Neural Degeneration and Repair - Gene Expression Profiling, Proteomics, and Systems Biology Wiley-VCH Verlag, Weinheim, 2008.

Müller J, Skogseid IM, Benecke R, Kupsch A, Trottenberg T, Poewe W, Schneider GH, Eisner W, Wolters A, Müller JU, Deuschl G, Pinsker MO, Roeste GK, Vollmer-Haase J, Brentrup A, Krause M, Tronnier V, et. al. [Schnitzler A]; Deep Brain Stimulation for Dystonia Study Group. Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial. Movement Disorders 2008; 23: 131-134.

Müller K, Aschersleben G, Schmitz F, Schnitzler A, Freund HJ, Prinz W. Inter- versus intramodal integration in sensorimotor synchronization: a combined behavioral and magnetoencephalographic study. Experimental Brain Research 2008; 185: 309-318.

Nomi JS, Scherfeld D, Friederichs S, Schäfer R, Franz M, Wittsack HJ, Azari NP, Missimer J, Seitz RJ. On the neural networks of empathy: A principal component analysis of an fMRI study. Behavioral and Brain Functions 2008; 4: 41.

Pappert EJ, Germanson T; for the Myobloc/Neurobloc European Cervical Dystonia Study Group [Hefter H]. Botulinum toxin type B vs. A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial. Movement Disorders 2008, 23: 510-517.

Pieperhoff P, Südmeyer M, Hömke L, Zilles K, Schnitzler A, Amunts K. Detection of structural changes of the human brain in longitudinally acquired MR images by deformation field morphometry: methodological analysis, validation and application. Neuroimage 2008; 43: 269-287.

Pollok B, Rothkegel H, Schnitzler A, Paulus W, Lang N. The effect of rTMS over left and right dorsolateral premotor cortex on movement timing of either hand. European Journal of Neuroscience 2008; 27: 757-764.

Pollok B, Gross J, Kamp D, Schnitzler A. Evidence for anticipatory motor control within a cerebello-diencephalic-parietal network. Journal of Cognitive Neuroscience 2008; 20: 828-840.

Polman C, Kappos L, Freedman MS, Edan G, Hartung HP, Miller DH, Montalban X, Barkhof F, Selmaj K, Uitdehaag BM, Dahms S, Bauer L, Pohl C, Sandbrink R; for the BENEFIT investigators. Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b. Journal of Neurology 2008; 255: 480-487.

Schoebel FC, Jax T, Peters A, Kreis I, Siebler M, Heintzen MP. Patent foramen ovale: what causes water to flow uphill? - More views. International Journal of Cardiology 2008; 124: 45-46 (online).

Schott BH, Minuzzi L, Krebs RM, Elmenhorst D, Lang M, Winz OH, Seidenbecher CI, Coenen HH, Heinze HJ, Zilles K, Düzel E, Bauer A. Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. Journal of Neuroscience 2008; 28: 14311-14319.

Schröder A, Wist ER, Hömberg V. TENS and optokinetic stimulation in neglect theapy after cerebrovascular accident: a randomized controlled study. European Journal of Neurology2008; 15: 922-927.

Seitz RJ, Siebler M. Platelet GPIIb/IIIa receptor antagonists in human ischemic brain disease. Current Vascular Pharmacology 2008; 6: 29-36.

Seitz RJ, Schäfer R, Scherfeld D, Friederichs S, Popp K, Wittsack HJ, Azari NP, Franz M. Valuating other people's emotional face expression: a combined functional magnetic resonance imaging and electroencephalography study. Neuroscience 2008; 152: 713-722.

Seitz RJ, Matyas TA, Carey LM. Neural plasticity as a basis for motor learning and neurorehabilitation. Brain Impairment 2008; 9: 103-113.

Siebler M, Junghans U, Fiebach JB. Imaging in cerebrovascular atherosclerotic disease. Herz2008; 33: 482-488.

Stüve O, Gold R, Chan A, Mix E, Zettl U, Kieseier BC. a4-integrin antagonism with natalizumab; effects and adverse events. Journal of Neurology 2008; 255: 58-65.

Stüve O, Bennett JL, Hemmer B, Wiendl H, Racke MK, Bar-Or A, Hu W, Zivadinov R, Weber MS, Zamvil SS, Pacheco MF, Menge T, Hartung HP, Kieseier BC, Frohman EM. Pharmacological treatment of early multiple sclerosis. Drugs 2008; 68: 73-83.

Suchan B, Melde C, Herzog H. Hömberg V, Seitz RJ. Activation differences in observation of hand movements for imitation or velocity judgement. Behavioural Brain Research 2008; 188: 78-83.

Timmermann L, Braun M, Groiss S, Wojtecki L, Ostrowski S, Krause H, Pollok B, Südmeyer M, Ploner M, Gross J, Maarouf M, Voges J, Sturm V, Schnitzler A. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease. Movement Disorders 2008; 23: 218-227.

Timmermann L, Schnitzler A. Parkinson's disease: after the honeymoon. In: Reich SG (ed.) Movement Disorders: 100 instructive cases. Thomson Publishing Services, UK, 2008, in press.

Timmermann L, Butz M, Gross J, Ploner M, Südmeyer M, Kircheis G, Häussinger D, Schnitzler A. Impaired cerebral oscillatory processing in hepatic encephalopathy. Clinical Neurophysiology 2008; 119: 265-272.

van Zon K, Lord WP, Lagor C, Theiss S, Brosig T, Siebler M. Stroke navigator - a clinical decision support system for acute stroke. AMIA Annual Symposium Proceedings/AMIA Symposium 2008; 6: 1227

Veronel D, Ringelstein A, Cohnen M, Yong M, Siebler M, Seitz RJ. Systemic thrombolysis based on CT or MRI stroke imaging. Journal of Neuroimaging 2008; 18: 381-387.

Waschbisch A, Wintterle S, Lochmüller H, Walter MC, Wischhusen J, Kieseier BC, Wiendl H. Human muscle cells express the costimulatory molecule B7-H3, which modulates muscle-immune interactions. Arthritis and Rheumatism 2008; 58: 3600-3608.

Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, Hohlfeld R. Multiple Sclerosis Therapy Consensus Group. Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations. Journal of Neurology 2008; 255: 1449-1463.

Witt K, Daniels C, Reiff J, Krack P, Volkmann J, Pinsker MO, Krause M, Tronnier V, Kloss M, Schnitzler A, Wojtecki L, Bötzel K, Danek A, Hilker R, Sturm V, Kupsch A, Karner E, Deuschl G. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurology 2008; 7: 605-614.

Wittsack HJ, Wohlschläger AM, Ritzl EK, Kleiser R, Cohnen M, Seitz RJ, Mödder U. CT-perfusion imaging of the human brain: advanced deconvolution analysis using circulant singular value decomposition. Computerized Medical Imaging and Graphics 2008; 32: 67-77.

Zohren F, Toutzaris D, Klärner V, Hartung HP, Kieseier B, Haas R. The monoclonal anti VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans. Blood2008; 111: 3893-3895.

MediathekInformation und Wissen
LageplanSo finden Sie uns